Publication date: Aug 01, 2026
Heavy menstrual bleeding (HMB) is a common cause of iron deficiency (ID). The COVID-19 pandemic was associated with reduced access to routine healthcare with significant impacts on women’s health. The aim of this study is to improve our understanding of the effect of the pandemic associated lockdown on diagnosis and management of HMB and ID. An IRB-approved retrospective chart review was conducted on patients assigned female at birth aged 11-25 with HMB and ID presenting to Hasbro Children’s hematology clinic or inpatient service between March 2018 and February 2023. Patients were identified using ICD-10 codes and manual chart review. Of 224 patients included, 155 had iron deficiency anemia (IDA) and 69 had iron deficiency without anemia (IDwA). The annual incidence of IDA due to HMB increased by twofold from pre-pandemic levels (n = 14, 2018-2019; n = 18, 2019-2020) to pandemic/post-pandemic levels (n = 36, 2020-2021; n = 46, 2021-2022; n = 41, 2022-2023) (P
Semantics
| Type | Source | Name |
|---|---|---|
| disease | MESH | COVID-19 |
| disease | MESH | Iron Deficiency Anemia |
| disease | MESH | Heavy Menstrual Bleeding |
| disease | MESH | iron deficiency |
| disease | MESH | ICD |
| disease | MESH | included |
| disease | MESH | anemia |